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compound, mainly drugs but also a toxic compound
(Ghanemi, 2014a,b,c,d), always takes into consideration well-
known inﬂuencing factors such as the drug concentration,
drug–drug interactions (Ritter, 2009; Hamoud et al., 2014;
Tischer and Fontana, 2014; Yeh et al., 2014) or the type of
excipient or solvent used during the drug administration.
However, some factors can signiﬁcantly inﬂuence the activity
a drug or a compound can have on cells (Ghanemi,
2014a,b,c,d), tissues or organisms.
Drug interactions with food (Lin et al., 2008; Wang and
Sweet, 2012) and some natural products may signiﬁcantly
inﬂuence the efﬁcacy of a drug. Indeed, since food or natural
products used either as nutriments or as herbal preparations
such as tea may contain active compounds including ﬂavo-
noids, alkaloids and others, this could have the same conse-
quence as the drug–drug interactions between the drug and
the active compounds contained within the food and the natu-
ral compounds that may inhibit for example intestinal metabo-
lism and transport (Won et al., 2012).
Such concepts are extremely important mainly in therapeu-
tics especially that it is largely believed that ‘‘natural products’’
are safe and without any possible negative impact on health,
which is not always correct. In fact, modern pharmacology
has pointed out divers active compounds derived from natural
products such as Traditional Chinese Medicines (Boubertakh
et al., 2013; Ghanemi and Boubertakh, 2014) that are potential
candidates for drug development showing strong biological
activity and thus the potential interaction they may have with
drugs if taken simultaneously.
Chemical environment that may result from the ingested
food is also an important inﬂuencing factor. Indeed, elements
such as the stomach pH and the type of molecules taken or
administrated simultaneously with the drug might inﬂuence
the pharmacokinetics mainly by modifying the drug ionicstatus and by creating competitiveness between the drug and
the other molecules used as transporters during the absorption
into the circulation or into the site of drug action. Within this
context the chemical environment may also modify some prop-
erties of drug receptors such as the reported data about the
factor the G protein coupled receptor (Ghanemi et al., 2013)
that represents probably the most important therapeutic target
in the modern pharmacology (Ghanemi, 2013a,b; Ghanemi,
2014a,b,c,d) which shows how ‘‘chemistry’’ can change drugs
the drug receptor or cells properties (Ghanemi, 2014a,b,c,d)
and thus, modiﬁes drug activity.
Physical conditions such as temperature may have an
impact as well. For instance, temperature may inﬂuence the
chemistry of the drug or the molecules of the compounds with
which the drug interacts. Furthermore, the temperature may
lead to a modiﬁcation to some pharmacokinetic-related
parameters such as vasoconstrictions which inﬂuence both
drug absorption and drug elimination.
Drug metabolism parameters (Cheikh Rouhou et al.,
2013; Yang et al., 2013; Cheikh Rouhou and Haddad,
2014), in addition to the physiological or the pathological sta-
tus of the cells, the tissue or the patients represent other ele-
ments that should be considered as well. Indeed, a slow or an
active metabolism (due to genetic factors (Zanger and
Schwab, 2013) or alcohol abuse for example) will inﬂuence
drug elimination and, importantly, the metabolism will be
more obvious when the drug is used to treat metabolic dis-
eases. Physiological or pathological situations might exert
inﬂuence at different levels including both pharmacodynamics
and pharmacokinetics. For example a pregnant woman will
produce steroid hormones that may have the same blood
transporters as steroids drugs, an athlete would have a better
drug metabolism than a sedentary patient and a diabetic
patient would respond less to antihyperlipidemic agents com-
pared to non-diabetic patients if they are given to both
patients in the same dosage.
These factors should be considered by both clinicians
while prescribing therapies and researchers working on exper-
imental pharmacology to develop pharmacology toward opti-
mized laboratory conditions and more efﬁcient clinical
applications.
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